A non-competitive P55 TNF receptor antibody enhances the specific activity of lymphotoxin-α

Scandinavian Journal of Immunology

Volumn 43, Issue 4, 1996, Pages 439-448

  Medvedev, A E ^a   Laegreid, A ^a   Sundan, A ^a   Espevik, T ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LYMPHOTOXIN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CELL LINE; CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029962825     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-58.x     Document Type: Article

References (47)

1. Beutler B, Cerami A. The biology of cachectin/TNF - a primary mediator of the host response. Annu Rev Immunol 1989;7:625-55.
2. Beutler B. Cachectin/tumor necrosis factor and lymphotoxin. In: Sporn MB, Roberts A., eds. Peptide Growth Factors. Berlin: Springer-Verlag, 1990: 39-70.
3. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapuetic target. Annu Rev Med 1994;45:491-503.
4. Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 1991;285:199-212.
5. Pennica D, Nedwin GE, Hayflick JS et al. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984;312:724-9.
6. Eck MJ, Ultsch M, Rinderknecht E, de Vos AM, Sprang SR. The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution. J Biol Chem 1992;267:2119-22.
7. Smith CA, Farrah T, Goodwin RG. The TNF receptor super-family of cellular and viral proteins: activation, costimulation and death. Cell 1994;76:959-62.
8. Hohmann H-P, Remy R, Poschl B, van Loon APGM. Tumor necrosis factor-alpha and beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-κB at low receptor occupance within minutes after receptor binding. J Biol Chem 1990;265:15183-8.
9. Schoenfeld H-J, Poeschl B, Frey JR et al. Efficient purification of recombinant tumor necrosis factor-beta from escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors. J Biol Chem 1991;266:3863-9.
10. Loetscher H, Pan Y-CE, Lahm H-W et al. Molecular cloning and expression of the human 55 kDa tumor necrosis factor receptor. Cell 1990;61:351-9.
11. Schall TJ, Lewis M, Koller KJ et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990;61:361-70.
12. Dembic Z, Loetscher H, Gubler U et al. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 1990; 2:231-7.
13. Smith CA, Davis T, Anderson D et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990;248:1019-23.
14. Darnay BG, Reddy SAG, Aggarwal BB. Physical and functional association of a serine-threonine protein kinase to the cytoplasmic domain of the p80 form of the human tumor necrosis factor receptor in human histiocytic lymphoma U-937 cells. J Biol Chem 1994;269:19687-90.
15. Darnay BG, Reddy SAG, Aggarwal BB. Identification of a protein kinase associated with the cytoplasmic domain of the p60 tumor necrosis factor receptor. J Biol Chem 1994;269:20299-304.
16. Rothe M, Wong SC, Henzel WJ, Goeddel DV. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75kDa tumor necrosis factor receptor. Cell 1994;78:681-92.
17. Eck MJ, Sprang SR. The structure of tumor necrosis factor-alpha at 2.6-Å resolution - implication for receptor binding. J Biol Chem 1989;264:17595-605.
18. Espevik T, Brockhaus M, Loetscher H, Nonstad U, Shalaby R. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J Exp Med 1990;171:415-26.
19. Engelmann H, Holtmann H, Brakebusch C et al. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem 1990;265:14497-504.
20. Grell M, Scheurich P, Meager A, Pfizenmaier K. TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolisis. Lymphokine Cytokine Res 1993;12:143-8.
21. Porter AG. Human tumor necrosis factors-alpha and beta: differences in their structure, expression and biological properties. FEMS Microbio Immunol 1990;2:193-200.
22. Locksley RM, Heinzel FP, Shepard HM et al. Tumor necrosis factor-alpha and beta differ in their capacities to generate interleukin-1 release from human endothelial cells. J Immunol 1987;139:1891-5.
23. Desch CE, Dobrina A, Aggarwal BB, Harlan JM. Tumor necrosis factor-alpha exhibits greater proinflammatory activity than lymphotoxin in vitro. Blood 1990;75:2030-4.
24. Oster W, Lindemann A, Horn S, Mertelsmann R, Herrmann F. Tumor necrosis factor (TNF)-alpha but not TNF-beta induces secretion of colony stimulating factor for macrophages (CSF-1) by human monocytes. Blood 1987;70:1700-3.
25. Kramer SM, Carver ME, Apperson SM. Comparison of TNF-alpha and TNF-beta cytolitic biological activities in a serum-free bioassay. Lymphokine Research 1986;5:8139-43.
26. Browning J, Ribolini A. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines. J Immunol 1989;143:1859-67.
27. Kircheis R, Milleck J, Korobko VG, Shingarova LN, Schmidt HE. Differences in the biological activity of TNF-alpha and TNF-beta correlate with their different abilities for binding to the target cells. Eur Cytokine Network 1992;3:381-90.
28. Iwamoto S, Shibuya I, Takeda K, Takeda M. Lymphotoxin lacks effects on 75-kDa receptors in cytotoxicity in U-937 cells. Biochem Biophys Res Comm 1994;199:70-7.
29. + T cell hybridoma. J Immunol 1990;144:2582-91.
30. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol 1991; 147:1522-9.
31. Hohmann HP, Remy R, Brockhaus M, van Loon APGM. Two different cell types have different major receptors for human tumor necrosis factor (TNF-alpha). J Biol Chem 1989;264:14927-34.
32. Erikstein BJ, Smeland EB, Kiil Blomhoff H et al. Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur J Immunol 1991;21:1033-7.
33. Estrov Z, Kurzrork R, Pocsik S et al. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. J Exp Med 1993;177:763-74.
34. Paleolog EM, Delasalle S-AJ, Buurman WA, Feldmann M. Fuctional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells. Blood 1994;84:2578-90.
35. Galloway CJ, Madanat MS, Sarr T et al. Anti-tumor necrosis factor receptor and tumor necrosis factor agonist activity by an anti-idiotypic antibody. Eur. J Immunol 1992;22:3045-8.
36. Gray PW, Aggarwal BB, Beton CV et al. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature 1984;312:721-4.
37. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Meth. 1986;95:99-105.
38. Liabakk N-B, Sundan A, Lien E et al. The release of soluble p55 TNF receptor from U937 cells studied by a new p55 immunoassay. J Immunol. Methods 1993;163:145-54.
39. Meager A. A cytotoxic assay for tumour necrosis factor using a human rhabdomyosarcoma cell line. Immunol Methods 1991;144:141-3.
40. Dignam JD, Lebowitz RM, Roeder G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res 1983;11:1475-82.
41. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6-tetrachloro-3α,6α-diphenylglucouril. Biochem Biophys Res Comm 1978;80:849-57.
42. Browning JL, Ngam-ek A, Lawton P et al. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 1993;72: 847-56.
43. Crowe PD, Van Arsdale TL, Walter BN et al. A lymphotoxin-beta specific receptor. Science 1994;264:707-10.
44. Browning JL, Douglas I, Ngam-ek A et al. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. J Immunol 1995;154:33-46.
45. De-Togni P, Goellner J, Ruddle NH et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994;264:703-7.
46. Pfeffer K, Matsuyama T, Kundig TM et al. Mice deficient for the 55 kDa tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. Monocytogenes infection. Cell 1993;73:457-67.
47. Erickson SL, De Sauvage FJ, Kikly K et al. Decreased sensitivity to tumour necrosis factor but normal T-cell development in TNF receptor-2 deficient mice. Nature 1994;372:560-3.